Innovation Saving Lives
We are a biotechnology company with a proprietary epigenetic biomarker discovery platform, EpiSwitch™, based on the latest advances in regulatory genome architecture and its link to clinical outcomes and patient stratification.
EpiSwitch™ biomarkers based on chromosomal conformation signatures are a critical cog in personalised medicine.
Technology to select the right drug at the right dose at the right time for the right patient.